LONG-TERM SUSTAINABILITY
ENHANCED FUNCTIONALITY
SHARPEST VISION
+3.25
+2.75
+4.0
Reading and fine detail work Intermediate vision activities
+3.25
+2.75
+4.0
+3.25
+2.75
+4.0
Multimedia work
+3.25
+2.75
+4.0
+3.25
+2.75
+4.0
INDICATIONS AND IMPORTANT SAFETY INFORMATION FOR THE TECNIS
®
MULTIFOCAL FAMILY OF
1-PIECE IOLs
Rx Only
INDICATIONS: The TECNIS® Multifocal 1-Piece Intraocular Lenses are indicated for primary implantation for the visual correction of aphakia in adult patients
with and without presbyopia in whom a cataractous lens has been removed by phacoemulsification and who desire near, intermediate, and distance vision with
increased spectacle independence. The intraocular lenses are intended to be placed in the capsular bag. WARNINGS: Physicians considering lens implantation
should weigh the potential risk/ benefit ratio for any conditions described in the Directions for Use that could increase complications or impact patient outcomes.
Multifocal IOL implants may be inadvisable in patients where central visual field reduction may not be tolerated, such as macular degeneration, retinal pigment
epithelium changes, and glaucoma. The lens should not be placed in the ciliary sulcus. Inform patients about the possibility that a decrease in contrast sensitivity
and an increase in visual disturbances may affect their ability to drive a car under certain environmental conditions, such as driving at night or in poor visibility
conditions.
PRECAUTIONS: Prior to surgery, inform prospective patients of the possible risks and benefits associated with the use of this device and provide a
copy of the patient information brochure to the patient. The long-term effects of intraocular lens implantation have not been determined. Secondary glaucoma
has been reported occasionally in patients with controlled glaucoma who received lens implants. Do not reuse, resterilize or autoclave. ADVERSE EVENTS: The rates of
surgical re-interventions, most of which were non-lens related, were statistically higher than the FDA grid rate for both the ZMB00 (+4.00 D) and ZLB00 (+3.25 D) lens
models. For the ZMB00, the surgical re-intervention rates were 3.2% for first eyes and 3.3% for second eyes. The re-intervention rate was 3.3% for both the first and second
eyes in the ZLB00 group.
ATTENTION: Reference the Directions for Use for a complete listing of Indications and Important Safety Information.
TECNIS is a trademark owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates.
© 2016 Abbott Medical Optics Inc. | www.AbbottMedicalOptics.com | PP2016CT0580
The legacy you leave is the life I live. And with the
TECNIS® Multifocal Family of 1-Piece IOLs, you can
leave me a full range of vision as sharp as I am — with
enhanced focus where I'll use it most.
Don't wait to leave a legacy of excellent outcomes.
Start now with the TECNIS® Multifocal Family of IOLs.
TECNISIOL .COM
Start with ME.
DON'T JUST LEAVE A LENS.I
LEAVE A LEGACY.I
TRUST YOUR PATIENTS' VISION TO THE LEADER
IN PRESBYOPIA-CORRECTING IOLs.
